NCT02476955 2020-09-30Open-label Phase 1b Study of ARQ 092 in Combination With AnastrozoleArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 1 Terminated41 enrolled